Inimmune Corporation
Clinical trials sponsored by Inimmune Corporation, explained in plain language.
-
New nasal spray shows promise for ragweed allergy sufferers
Symptom relief CompletedThis study tested an experimental nasal spray called INI-2004 in 78 adults with ragweed allergies. Participants received either the spray or a placebo once a week for four weeks, then spent time in a room filled with ragweed pollen to see if symptoms improved. The goal was to che…
Phase: PHASE2 • Sponsor: Inimmune Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New allergy drug shows promise in early trial
Symptom relief CompletedThis early-stage study tested a new drug called INI-2004 in 68 healthy people and those with ragweed allergies. The goal was to check safety and how well it reduces nasal symptoms like sneezing and congestion. Researchers gave single or multiple doses and monitored side effects a…
Phase: PHASE1 • Sponsor: Inimmune Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC